Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
684
datasets available to search
ShareScore release 0.9.0
Dataset results
684 results for “Head and Neck Squamous Cell Carcinoma”
Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT03818061. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck.
ClinicalTrials.gov study NCT04445064. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)
ClinicalTrials.gov study NCT04675333. IPD Sharing: NO. Countries: 8. Publications: 0.
A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT01303237. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tazemetostat and Pembrolizumab in Patients With Pembrolizumab- or Nivolumab-Resistant, Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma
ClinicalTrials.gov study NCT04624113. IPD Sharing: NO. Countries: 1. Publications: 0.
PET/CT Follow up for Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05707078. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Paclitaxel (Albumin Bound),Bleomycin And Cisplatin Or Carboplatin for Recurrent Or Metastatic Squamous Cell Carcinoma Of The Head And Neck
ClinicalTrials.gov study NCT03830385. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head and Neck
ClinicalTrials.gov study NCT02015650. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cetuximab+Zimberelimab in Combination With Cisplatin and Nab-paclitaxel in Resctable Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06107114. IPD Sharing: NO. Countries: 1. Publications: 0.
The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensity Modulated Radiotherapy Versus Standard IMRT in Head and Neck Squamous Cell Carcinomas
ClinicalTrials.gov study NCT05187091. IPD Sharing: NO. Countries: 1. Publications: 0.
NT219 Combined With Standard of Care Biologic Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06919666. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
ClinicalTrials.gov study NCT06699212. IPD Sharing: NO. Countries: 3. Publications: 0.
Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT00855881. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Real-world Analysis on the Efficacy and Safety of Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma （neoHNSCC）
ClinicalTrials.gov study NCT06011993. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NC-6004 With 5-FU and Cetuximab for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT03109158. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
ClinicalTrials.gov study NCT06006169. IPD Sharing: Not stated. Countries: 1. Publications: 0.
NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery
ClinicalTrials.gov study NCT04588038. IPD Sharing: NO. Countries: 1. Publications: 0.
Low-Dose Radiotherapy and Anti-PD-1 Immunotherapy as Neoadjuvant Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT07371234. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of LVGN6051 Combination Therapy in Patient With Head and Neck Squamous Cell Carcinoma (HNSCC)
ClinicalTrials.gov study NCT06378177. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202
ClinicalTrials.gov study NCT06062420. IPD Sharing: YES. Countries: 20. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.